Memorial Regional Hospital/Joe DiMaggio Children's Hospital

Summary

Memorial Regional Hospital/Joe DiMaggio Children's Hospital is a medical facility located in Hollywood, Florida. This center is recognized for care of Cancer, Lung Cancer, Brain Tumor, Breast Cancer, Acute Lymphoblastic Leukemia and other specialties. Memorial Regional Hospital/Joe DiMaggio Children's Hospital is involved with conducting 210 clinical trials across 513 conditions. There are 16 research doctors associated with this hospital, such as Iftikhar Hanif, Luis E. Raez, Delia C. Guaqueta, and Atif Hussein.

Top PIs

Clinical Trials running at Memorial Regional Hospital/Joe DiMaggio Children's Hospital

Brain Tumor

Lung Cancer

Wilms Tumor

Testicular cancer

Bladder Cancer

Neuroblastoma

Breast Cancer

Cancer

Burkitt Lymphoma

Esophageal cancer

Radiation Therapy vs Observation

for Meningioma

This trial studies if radiation therapy helps prevent the return of grade II meningioma after surgery. Radiation therapy uses powerful x-rays to destroy any leftover cancer cells. The goal is to see if this improves patient outcomes compared to just monitoring them. Radiation therapy has shown success in stabilizing tumor growth and reducing recurrence risk.

Recruiting

2 awards

Phase 3

12 criteria

Stereotactic Radiosurgery vs. HA-WBRT + Memantine

for Brain Cancer

Stereotactic radiosurgery (SRS) is a commonly used treatment for brain tumors. It is a one-day (or in some cases two day), out-patient procedure during which a high dose of radiation is delivered to small spots in the brain while excluding the surrounding normal brain. Whole brain radiation therapy with hippocampal avoidance (HA-WBRT) is when radiation therapy is given to the whole brain, while trying to decrease the amount of radiation that is delivered to the area of the hippocampus. The hippocampus is a brain structure that is important for memory. Memantine is a drug that is given to help relieve symptoms that can be caused by WBRT, including problems with memory and other mental symptoms. Health Canada, the regulatory body that oversees the use of drugs in Canada, has not approved the sale or use of memantine in combination with WBRT to treat this kind of cancer, although they have allowed its use in this study.

Recruiting

2 awards

Phase 3

Selumetinib vs. Chemotherapy

for Brain Cancer

This trial is comparing a new drug, selumetinib, with standard chemotherapy to treat patients with a specific type of brain tumor. The patients do not have a certain genetic mutation and are not affected by a genetic disorder. Selumetinib works by blocking enzymes needed for tumor growth, while the standard drugs kill or stop tumor cells from dividing.

Recruiting

2 awards

Phase 3